Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02848430 · ClinicalTrials.gov registry record · NA
Hop Botanical Dietary Supplements - Metabolism and Safety in Women
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02848430 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 22 participants.
The verdict
NCT02848430, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Human safety studies were carried out to test whether hop botanical dietary supplements used by peri- and post-menopausal women are safe to use with Food and Drug Administration (FDA)-approved drugs. To test this, a hop dietary supplement (previously tested in women at the University of Illinois at Chicago without any harmful effects) was given with four selected FDA-approved drugs to determine if the hop supplement can increase or decrease how these medications are absorbed, metabolized and excreted by the human body. Preclinical studies had predicted that the hop supplement might affect the metabolism or break down of these probe drugs.
Interventions
- DIETARY_SUPPLEMENT Humulus lupulus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-08-15 |
| Est. Completion | 2019-09-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02848430
The ClinicalTrials.gov registry entry for NCT02848430 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Humulus lupulus is the first listed.
NCT02848430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02848430 about?
NCT02848430 is a clinical study titled "Hop Botanical Dietary Supplements - Metabolism and Safety in Women". Human safety studies were carried out to test whether hop botanical dietary supplements used by peri- and post-menopausal women are safe to use with Food and Drug Administration (FDA)-approved drugs. To test this, a hop dietary supplement (previously tested in women at the University of Illinois at ...
What is the current status of trial NCT02848430?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-08-15. Estimated completion is 2019-09-24.
What interventions are being tested in trial NCT02848430?
The interventions under investigation include: Humulus lupulus (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02848430?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.